Chemed EV/EBIT CHE

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026: 19.5×
10-year median: 21.6×
Against its 10-year history: 29th; percentile: 0 is its lowest day, 100 its highest
10-year range: 12.8× to 32.0×
Peer median: 20.0×

Chemed's EV/EBIT is 19.5× as of Oct 23, 2026.

That is below its ten-year median of 21.6×, lower than on 71% of days in the last ten years.

Over that time it ranged from 12.8× in Nov 2016 to 32.0× in Feb 2020.

The median for 10 hospital and care facility stocks of a similar size is 20.0×.

EV/EBIT over time

median 21.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	19.5×	15.2×	21.0×
2025	17.5×	16.2×	24.1×
2024	21.3×	21.3×	29.0×
2023	28.2×	20.8×	28.6×
2022	21.3×	17.6×	22.9×
2021	21.3×	17.8×	27.1×
2020	26.3×	22.1×	32.0×
2019	28.6×	19.2×	28.8×
2018	19.5×	18.7×	25.0×
2017	19.8×	15.6×	20.1×
2016	15.2×	11.8×	15.2×
2015	14.1×	11.8×	15.3×
2014	12.4×	9.0×	14.6×
2013	9.1×	7.7×	10.4×
2012	8.9×	7.5×	9.5×
2011	7.9×	7.8×	11.6×

Against its peers

Companies in Medical - Care Facilities nearest Chemed's size, closest first, today.

Company	EV/EBIT
CHEChemed	19.5×
PACSPACS	18.6×
SHCSotera Health	26.1×
CONConcentra Group Holdings Parent	17.2×
LFSTLifeStance Health	63.6×
OPCHOption Care Health	16.9×
ENSGEnsign	21.5×
UHSUniversal Health Services	7.7×
DVADavita	10.4×
BTSGBrightSpring Health Services	29.0×
NHCNational Healthcare	23.8×
Peer median	20.0×

Where Chemed ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Chemed

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.